FilingSEC EDGAR424B3
Biodexa Pharmaceuticals Files Prospectus Supplement for Resale of Common Stock
· SEC accepted
StageRegistration
Filing content
The company filed a prospectus supplement for the resale of up to 127,754,750 ordinary shares represented by 2,555,095 ADSs issuable upon the exercise of existing warrants.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…